Cargando…
Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b
PURPOSE: Multiple sclerosis (MS) is a chronic demyelinating, degenerative disease requiring long-term treatment. Patient adherence to treatment may be challenging in such scenarios, especially since treatment often involves self-injection, for example, with interferon beta-1b during therapy. BETACON...
Autores principales: | Weller, Ivonne, Saake, Anna, Schreiner, Thomas, Vogelreuter, Julika, Petroff, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501165/ https://www.ncbi.nlm.nih.gov/pubmed/26185425 http://dx.doi.org/10.2147/PPA.S85917 |
Ejemplares similares
-
Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™)
por: Ziemssen, Tjalf, et al.
Publicado: (2015) -
Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors
por: Barone, Donald A., et al.
Publicado: (2016) -
Real-World Assessment of Interferon-β-1b and Interferon-β-1a Adherence Before and After the Introduction of the BETACONNECT(®) Autoinjector: A Retrospective Cohort Study
por: Butler, Oisín, et al.
Publicado: (2021) -
Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study
por: Kleiter, Ingo, et al.
Publicado: (2017) -
Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT(®) Autoinjector: A Prospective Observational Cohort Study
por: Köhler, Wolfgang, et al.
Publicado: (2021)